Development of a MARTINI Coarse-Grained Model of the Rosette Nanotubes

20 June 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A significant challenge in healthcare is providing effective treatments with minimal side effects. This is particularly true in chemotherapies, where side effects can range from nausea to chemo-induced seizures. As a result, the area of nanotechnology can provide targeted drug delivery systems to boost the efficacy of the drugs and potentially minimize the side effects for more personalized treatment. To develop these systems, building models can complement experiments and provide guidance on which systems could be more effective to reduce research and development costs and potentially speed up the process. In this paper, the first-of-its-kind coarse-grained MARTINI v2.2 model of a biocompatible rosette nanotube was developed, tested, and compared to previ- ous simulation and experimental work. The coarse-grained model structure was in good agreement with the all-atom structure based on the nanotube characterizations performed (eg. axial rise was approximately 0.39 nm, which is close to experimen- tal values). However, more optimization is needed, especially for when the RNT is functionalized.

Keywords

MARTINI
rosette nanotubes
coarse-grained
molecular dynamics

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.